raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:238583

Hyperphenylalaninemia due to tetrahydrobiopterin deficiency

Synonyms: Hyperphenylalaninemia due to BH4 deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

A disorder of pterin metabolism characterized by tetrahydrobiopterin (BH4) biosynthesis or recycling deficiencies, leading to central dopamine and serotonin deficiency, characterized by infantile-onset neurological disease of variable severity ranging from mild forms with minor neurological development to severe forms with hypotonia, developmental delay, complex movement disorder dominated by dystonia or dystonia parkinsonism.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHyperphenylalaninemia due to tetrahydrobiopterin deficiencyHyperphenylalaninemia due to BH4 deficiency
frHyperphénylalaninémie par déficit en tétrahydrobioptérineHyperphénylalaninémie par déficit en BH4
deHyperphenylalaninämie durch Tetrahydrobiopterin-MangelHyperphenylalaninämie durch BH4-Mangel · Hyperphenylalaninämie, nicht-phenylketonurische
esHiperfenilalaninemia por deficiencia de tetrahidrobiopterinaHiperfenilalaninemia no fenilcetonúrica · Hiperfenilalaninemia por deficiencia de BH4
itIperfenilalaninemia da deficit di tetraidrobiopterinaIperfenilalaninemia da deficit di BH4 · Iperfenilalaninemia da deficit di tetraidrobiopterina · Iperfenilalaninemia non fenilchetonurica
nlHyperfenylalaninemie door deficiëntie van tetrahydrobiopterineHyperfenylalaninemie door BH4-deficiëntie · Niet-fenylketonurische hyperfenylalaninemie
ptHiperfenilalaninemia por deficiência de tetrahidrobiopterina
plHiperfenyloalaninemiaHiperfenylalaninemia nie związana z fenyloketonurią · Hiperfenyloalaninemia z powodu niedoboru BH4 · Hiperfenyloalaninemia z powodu niedoboru tetrahydrobiopteryny
csHyperfenylalaninemieNon-fenylketonurická hyperfenylalaninemie · Hyperfenylalaninémie způsobená BH4 deficitem · Hyperfenylalaninémie způsobená deficitem tetrahydrobiopterinu
ukГіперфенілаланінемія внаслідок дефіциту тетрагідробіоптеринуГіперфенілаланінемія внаслідок дефіциту BH4
zh四氢生物蝶呤缺乏性高苯丙氨酸血症四氢生物蝶呤缺乏所致高苯丙氨酸血症
trTetrahidrobiopterin eksikliğine bağlı hiperfenilalaninemiFenilketonürik olmayan hiperfenilalaninemi · BH4 eksikliğine bağlı hiperfenilalaninemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM233910BTNTvalidated
OMIM261630BTNTvalidated
OMIM261640BTNTvalidated
OMIM264070BTNTvalidated
ICD-10E70.1NTBTattributedvalidated
ICD-115C59.01NTBTindexvalidated
MONDO0016543Evalidated
UMLSC0751436Evalidated
GARD7751Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (4):

4

Genes

0 direct · 4 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
GCH1ORPHA:2102GTP cyclohydrolase I deficiencyDisease-causing germline mutation(s) inAssessedHGNC:4193ENSG0000013197960022514q22.2GTP cyclohydrolase 1
PCBD1ORPHA:1578Pterin-4 alpha-carbinolamine dehydratase deficiencyDisease-causing germline mutation(s) inAssessedHGNC:8646ENSG0000016622812609010q22.1pterin-4 alpha-carbinolamine dehydratase 19760199[PMID]
PTSORPHA:136-pyruvoyl-tetrahydropterin synthase deficiencyDisease-causing germline mutation(s) inAssessedHGNC:9689ENSG0000015078761271911q23.16-pyruvoyltetrahydropterin synthase
QDPRORPHA:226Dihydropteridine reductase deficiencyDisease-causing germline mutation(s) inAssessedHGNC:9752ENSG000001515526126764p15.32quinoid dihydropteridine reductase9744478[PMID]
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 1 000 0000.22 / 100 000JapanValue and classValidated6468444[PMID]
Point prevalence1-9 / 1 000 0000.2 / 100 000WorldwideValue and classValidated[EXPERT]
Point prevalence1-9 / 1 000 0000.21 / 100 000BrazilValue and classValidated35209917[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

24 annotations · validated 2024-10-29
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0004923Hyperphenylalaninemia
Frequent (79-30%)
HP:0040210Abnormal circulating biopterin concentration
HP:0040206Abnormal circulating neopterin concentration
HP:0040416Abnormal urinary nitrogen compound level
HP:0000708Atypical behavior
HP:0003785Decreased CSF homovanillic acid concentration
HP:0003781Excessive salivation
HP:0001252Hypotonia
HP:0012758Neurodevelopmental delay
Occasional (29-5%)
HP:0002135Basal ganglia calcification
HP:0100543Cognitive impairment
HP:6000482Decreased circulating catecholamine concentration
HP:0000750Delayed speech and language development
HP:0001332Dystonia
HP:0033594Elevated urinary 7-biopterin level
HP:0001276Hypertonia
HP:0002917Hypomagnesemia
HP:0004904Maturity-onset diabetes of the young
HP:0000252Microcephaly
HP:0010553Oculogyric crisis
HP:0001300Parkinsonism
HP:0002421Poor head control
HP:0001250Seizure
HP:0002360Sleep abnormality

Run the differential on the 1 obligate / very frequent terms

Annotation source: 32456656[PMID]_33903016[PMID]_21937252[PMID]

7

Sources for this card